Bureau of Tuberculosis Control

Information for Health Care Providers

Page Contents

• • Reporting
• • General Information
• • Forms
• • Treatment Guidelines
• • Medical Fact Sheets

Tuberculosis Information Kit for Health Care Providers

Reporting

Report Communicable Diseases and Outbreaks

• Reporting Requirements for Tuberculosis Fact Sheet (PDF)
• Universal Reporting Form (PDF)

General Information

• Tuberculosis (TB): Clinical Policies and Protocols, March 2008 (PDF) NEW
• Tuberculosis Epidemiology: New York City, 2006 (PDF) NEW
• Data Requests Protocol (PDF)
• How to Handle Occupational Exposure to Tuberculosis (PDF)
• Mycobacterium bovis in NYC- Health Alert (PDF)
• Reporting Requirement Fact Sheet (Revised December 2007) (PDF)
• Sputum Collection Instructions (English (PDF) [Spanish]
• Universal Reporting Form (PDF)

back to top

Forms

• Directly Observed Therapy (DOT) Referral Form (PDF)
• Laboratory Report Form (TB 159) (PDF)
• Mycobacteriology Request Form (TN 50) (PDF)
• Report of Patient Services (TB 65) (PDF)
• Reporting Form for Latent TB Infection Treatment (TB 78) (PDF)

back to top

Treatment Guidelines

• City Health Information: Testing and Treatment for Latent Tuberculosis Infection (April 2006) (PDF)
• Antiretroviral Drug Use with Rifampin and Rifabutin Card (November 2005) (PDF)
• Antiretroviral Drugs and the Treatment of Tuberculosis (Revised February 2007) (PDF)
• City Health Information: Tuberculosis Treatment (December 2003) (PDF)
• Clinical Policies and Protocols (Third Edition: June 1999) (PDF)
• Hospitalization and Community Discharge protocol (Revised March 2007) (PDF)
• Rifapentine for TB Treatment (Dear Colleague Letter - March 2003) (PDF)
• Rifapentine for the Treatment of Pulmonary Tuberculosis in the Chest Centers (Revised: December, 2003) (PDF)
• Rifapentine Patient Facts (PDF)
• Tuberculosis& Pregnancy

back to top

Medical Fact Sheets

• Aminosalicylic Acid (PAS) Granules for TB Treatment
• Chest Radiograph following a Positive Tuberculin Skin Test
• Commissioner's Orders for Adherence to Anti-TB Treatment
• Completion of Treatment for Tuberculosis
• Culture-Negative Tuberculosis
• Directly Observed Therapy
• Evaluation and Follow-up of Contacts of Persons with TB
• False-Positive Cultures for Mycobacterium tuberculosis
• Fluoroquinolone Resistance and TB Treatment
• Identifying and Treating "Old Tuberculosis"
• Importance of Rifampin
• M. bovis
• Monitoring Sputum during TB Treatment
• Multidrug-Resistant Tuberculosis
• Rapid Diagnostic Tests for Tuberculosis
• Rifater® and Rifamate® in the Treatment of TB
• Tuberculosis Control Partnership in New York City
• Tuberculosis Surveillance of Health Care Workers: Tuberculin Skin Testing

back to top